Skip to main content
logo
Ono Pharmaceutical Co., Ltd. (TYO:4528)
Japan flag Japan · Delayed Price · Currency is JPY
2,266.00
-57.00 (-2.45%)
At close: Jan 28, 2026

Ono Pharmaceutical Revenue

Ono Pharmaceutical had revenue of 129.60B JPY in the quarter ending September 30, 2025, with 5.65% growth. This brings the company's revenue in the last twelve months to 503.67B, up 4.00% year-over-year. In the fiscal year ending March 31, 2025, Ono Pharmaceutical had annual revenue of 486.87B, down -3.14%.

Revenue (ttm)
503.67B
Revenue Growth
+4.00%
P/S Ratio
2.11
Revenue / Employee
117.49M
Employees
4,287
Market Cap
1.06T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025486.87B-15.80B-3.14%
Mar 31, 2024502.67B55.49B12.41%
Mar 31, 2023447.19B85.83B23.75%
Mar 31, 2022361.36B52.08B16.84%
Mar 31, 2021309.28B16.86B5.77%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Otsuka Holdings2.42T
Astellas Pharma2.01T
Daiichi Sankyo Company1.98T
Chugai Pharmaceutical1.21T
Kyowa Kirin482.21B
Santen Pharmaceutical291.48B
JCR Pharmaceuticals37.78B
Perseus Proteomics121.00M
Revenue Rankings

Ono Pharmaceutical News

More News